GALILEO
Report
- Report Number
- 1034569-2008-00089
- Event Type
- Malfunction
- Date Received
- April 3, 2008
- Date of Event
- March 12, 2008
- Report Date
- March 24, 2008
- Manufacturer
- IMMUCOR, INC.
- Product Code
- KSZ
- PMA / PMN Number
- BK040013
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NJ, US
- Reporter Occupation
- MEDICAL TECHNOLOGIST
Narratives
INSTRUMENT IMAGES WERE REVIEWED; THE UNEXPECTED RESULTS WERE CONFIRMED. TESTING PERFORMED WITH RETENTION ANTI-A, LOT 101673, 101674 WITH IN HOUSE DONOR SAMPLES REVEALED TYPE A RED CELL STICKING IN THE ANTI-A WELLS. TO PREVENT THE STICKING, IN HOUSE STUDIES FOUND THAT PIPETTING THE REAGENTS INTO THE WELLS BEFORE THE SAMPLE RED CELLS GREATLY REDUCED THE STICKING. IN HOUSE COMPARISON TESTING OF THE NEW REAGENT-FIRST PIPETTING ORDER TO THE EXISTING SAMPLE-FIRST PIPETTING ORDER SHOWED NO UNEXPECTED NEGATIVE ANTI-A REACTIONS WITH THE NEW PIPETTING ORDER. SOME UNEXPECTED NEGATIVE REACTIONS WERE OBSERVED DURING TESTING WITH THE CURRENT ASSAY. CUSTOMERS WERE NOTIFIED OF THE MODIFICATION TO THE ASSAY ON 9/20/07.THIS FACILITY DID NOT HAVE THE MODIFIED ABO ASSAY SOFTWARE INSTALLED. CUSTOMER LOADED THE MODIFIED ASSAY. SINCE LOADING THE FWD ASSAY MODIFICATION, THEY REPORTED THE ISSUES HAVE NOT REOCCURRED. ACCORDING TO THE GALILEO OPERATOR MANUAL, FORWARD ONLY ABO-RH TESTING HAS A HIGHER RISK OF MISTYPE DUE TO THE ABSENCE OF THE REVERSE TYPE RESULTS. HAZARDOUS MISTYPES MAY OCCUR, SUCH AS AN A SAMPLE BEING INTERPRETED AS A GROUP AB, OR AN RH (D) NEGATIVE SAMPLE BEING INTERPRETED AS RH(D) POSITIVE. FOR THIS REASON, ABO-RH RESULTS SHOULD ALWAYS BE COMPARED TO THE PATIENT OR DONOR'S HISTORY.
CUSTOMER REPORTED AN ABO MISTYPE ON THE GALILEO. A PATIENT HISTORICALLY TYPED AS AN A POSITIVE, BUT TYPED AS AN O POSITIVE ON THE GALILEO. THE SAMPLE WAS REPEATED AND GAVE THE EXPECTED REACTIONS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GALILEO | AUTOMATED BLOOD BANK ANALYZER | KSZ | IMMUCOR, INC. | 10054 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |